Validation of developed iontophoretic device with disposable patches for pain management in clinical settings.
Not Applicable
Completed
- Conditions
- Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
- Registration Number
- CTRI/2019/09/021446
- Lead Sponsor
- Research Institute and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Adult cancer patients aged 18 years and older coming for IV cannulation
Exclusion Criteria
clinical evidence of dehydration, lidocaine allergy, decreased mental status, or patients with pacemaker
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcome of the study will help to establish iontophoresis technique as a means of providing dermal anesthesia, which will be non-invasive, cost-effective and will have shorter onset time period of drug delivery as compared to the EMLA cream.Timepoint: The onset time taken by EMLA cream to provide therapeutic anesthesia is approximately 45-60 minutes. So, there is a strong need to reduce this onset time. Hence in the present work, by using iontophoresis technique, lignocaine will be delivered in shorter time (5-10minutes) thereby reducing the onset time and cost.
- Secondary Outcome Measures
Name Time Method Comparison of Pain level during cannulationTimepoint: Two Times with iontophoresis or EMLA & without iontophoresis device or EMLA